Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lill Trogstad

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of the American Heart Association|May 15, 2018
Pregnancy-Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population-Based Norwegian CohortGrace M Egeland, Svetlana Skurtveit, Anne Cathrine Staff, et al.
Preventive Medicine|March 8, 2021
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysisAllison Portnoy, Kine Pedersen, Lill Trogstad, et al.
European Journal of Neurology|December 4, 2025
New-Onset Headache After SARS-CoV-2 Infection and Vaccination: Results From Three Population-Based Cohorts in NorwayKristine Blix, Ida Laake, Ida Henriette Caspersen, et al.
The Journal of Infectious Diseases|October 19, 2022
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian CohortIda Laake, Siri N Skodvin, Kristine Blix, et al.
BMJ Public Health|February 28, 2025
How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months' follow-up: a national observational cohort and matched cohort studyHanna M Ollila, Osvaldo Fonseca-Rodríguez, Ida Henriette Caspersen, et al.
Vaccine|March 27, 2026
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infectionsAnna Hayman Robertson, Asia-Sophia Wolf, Even Fossum, et al.
NPJ Vaccines|November 29, 2024
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderlyRatnadeep Mukherjee, Linn Margrethe Eggesbø, Asia-Sophia Wolf, et al.
European Journal of Epidemiology|January 18, 2020
Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort studyNina Gunnes, Håkon Kristian Gjessing, Inger Johanne Bakken, et al.
The Lancet. Healthy Longevity|May 6, 2023
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort studyAnthony Ravussin, Anna Hayman Robertson, Asia-Sophia Wolf, et al.
Plos One|January 30, 2025
Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicatorsGunnar Rø, Trude Marie Lyngstad, Elina Seppälä, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|May 15, 2018
Pregnancy-Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population-Based Norwegian CohortGrace M Egeland, Svetlana Skurtveit, Anne Cathrine Staff, et al.
Preventive Medicine|March 8, 2021
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysisAllison Portnoy, Kine Pedersen, Lill Trogstad, et al.
European Journal of Neurology|December 4, 2025
New-Onset Headache After SARS-CoV-2 Infection and Vaccination: Results From Three Population-Based Cohorts in NorwayKristine Blix, Ida Laake, Ida Henriette Caspersen, et al.
The Journal of Infectious Diseases|October 19, 2022
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian CohortIda Laake, Siri N Skodvin, Kristine Blix, et al.
BMJ Public Health|February 28, 2025
How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months' follow-up: a national observational cohort and matched cohort studyHanna M Ollila, Osvaldo Fonseca-Rodríguez, Ida Henriette Caspersen, et al.
Vaccine|March 27, 2026
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infectionsAnna Hayman Robertson, Asia-Sophia Wolf, Even Fossum, et al.
NPJ Vaccines|November 29, 2024
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderlyRatnadeep Mukherjee, Linn Margrethe Eggesbø, Asia-Sophia Wolf, et al.
European Journal of Epidemiology|January 18, 2020
Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort studyNina Gunnes, Håkon Kristian Gjessing, Inger Johanne Bakken, et al.
The Lancet. Healthy Longevity|May 6, 2023
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort studyAnthony Ravussin, Anna Hayman Robertson, Asia-Sophia Wolf, et al.
Plos One|January 30, 2025
Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicatorsGunnar Rø, Trude Marie Lyngstad, Elina Seppälä, et al.
Pageof 9